KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Tax Rate (2016 - 2025)

Historic Tax Rate for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to 0.03%.

  • Travere Therapeutics' Tax Rate fell 1200.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.04% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Travere Therapeutics' Tax Rate stood at 0.03%, which was down 1200.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Tax Rate ranged from a high of 0.15% in Q3 2024 and a low of 0.58% during Q1 2021
  • For the 5-year period, Travere Therapeutics' Tax Rate averaged around 0.09%, with its median value being 0.08% (2023).
  • In the last 5 years, Travere Therapeutics' Tax Rate plummeted by -1051600bps in 2021 and then skyrocketed by 5200bps in 2022.
  • Over the past 5 years, Travere Therapeutics' Tax Rate (Quarter) stood at 0.0% in 2021, then tumbled by -1534bps to 0.07% in 2022, then decreased by -4bps to 0.08% in 2023, then surged by 255bps to 0.12% in 2024, then tumbled by -74bps to 0.03% in 2025.
  • Its Tax Rate stands at 0.03% for Q3 2025, versus 0.16% for Q2 2025 and 0.09% for Q1 2025.